183 related articles for article (PubMed ID: 27234807)
1. Centrosome associated genes pattern for risk sub-stratification in multiple myeloma.
Kryukov F; Nemec P; Radova L; Kryukova E; Okubote S; Minarik J; Stefanikova Z; Pour L; Hajek R
J Transl Med; 2016 May; 14(1):150. PubMed ID: 27234807
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma.
Dementyeva E; Kryukov F; Kubiczkova L; Nemec P; Sevcikova S; Ihnatova I; Jarkovsky J; Minarik J; Stefanikova Z; Kuglik P; Hajek R
J Transl Med; 2013 Mar; 11():77. PubMed ID: 23522059
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity and centrosome-associated genes in multiple myeloma.
Kryukov F; Nemec P; Dementyeva E; Kubiczkova L; Ihnatova I; Budinska E; Jarkovsky J; Sevcikova S; Kuglik P; Hajek R
Leuk Lymphoma; 2013 Sep; 54(9):1982-8. PubMed ID: 23323949
[TBL] [Abstract][Full Text] [Related]
4. The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.
Papanikolaou X; Alapat D; Rosenthal A; Stein C; Epstein J; Owens R; Yaccoby S; Johnson S; Bailey C; Heuck C; Tian E; Joiner A; van Rhee F; Khan R; Zangari M; Jethava Y; Waheed S; Davies F; Morgan G; Barlogie B
Leukemia; 2015 Aug; 29(8):1713-20. PubMed ID: 25753926
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine.
Meissner T; Seckinger A; Rème T; Hielscher T; Möhler T; Neben K; Goldschmidt H; Klein B; Hose D
Clin Cancer Res; 2011 Dec; 17(23):7240-7. PubMed ID: 21986844
[TBL] [Abstract][Full Text] [Related]
6. Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
Shaughnessy JD; Haessler J; van Rhee F; Anaissie E; Pineda-Roman M; Cottler-Fox M; Hollmig K; Zangari M; Mohiuddin A; Alsayed Y; Grazziutti M; Epstein J; Crowley J; Barlogie B
Br J Haematol; 2007 Jun; 137(6):530-6. PubMed ID: 17489983
[TBL] [Abstract][Full Text] [Related]
7. Low-risk identification in multiple myeloma using a new 14-gene model.
Chen T; Berno T; Zangari M
Eur J Haematol; 2012 Jul; 89(1):28-36. PubMed ID: 22620863
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
van Beers EH; van Vliet MH; Kuiper R; de Best L; Anderson KC; Chari A; Jagannath S; Jakubowiak A; Kumar SK; Levy JB; Auclair D; Lonial S; Reece D; Richardson P; Siegel DS; Stewart AK; Trudel S; Vij R; Zimmerman TM; Fonseca R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):555-562. PubMed ID: 28735890
[TBL] [Abstract][Full Text] [Related]
10. Improved risk stratification in myeloma using a microRNA-based classifier.
Wu P; Agnelli L; Walker BA; Todoerti K; Lionetti M; Johnson DC; Kaiser M; Mirabella F; Wardell C; Gregory WM; Davies FE; Brewer D; Neri A; Morgan GJ
Br J Haematol; 2013 Aug; 162(3):348-59. PubMed ID: 23718138
[TBL] [Abstract][Full Text] [Related]
11. Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.
Hermansen NE; Borup R; Andersen MK; Vangsted AJ; Clausen NT; Kristensen DL; Nielsen FC; Gimsing P
Int J Lab Hematol; 2016 Jun; 38(3):298-307. PubMed ID: 27027250
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
[TBL] [Abstract][Full Text] [Related]
13. Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.
Sarasquete ME; Martínez-López J; Chillón MC; Alcoceba M; Corchete LA; Paiva B; Puig N; Sebastián E; Jiménez C; Mateos MV; Oriol A; Rosiñol L; Palomera L; Teruel AI; González Y; Lahuerta JJ; Bladé J; Gutiérrez NC; Fernández-Redondo E; González M; San Miguel JF; García-Sanz R
Br J Haematol; 2013 Oct; 163(2):223-34. PubMed ID: 23952215
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.
Hao S; Lin P; Medeiros LJ; Fang L; Carballo-Zarate AA; Konoplev SN; Sargent RL; Weber DM; Thomas SK; Manasanch EE; Orlowski RZ; Lu X
Mod Pathol; 2017 Oct; 30(10):1378-1386. PubMed ID: 28664940
[TBL] [Abstract][Full Text] [Related]
15. Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma.
Dementyeva E; Nemec P; Kryukov F; Muthu Raja KR; Smetana J; Zaoralova R; Greslikova H; Kupska R; Kuglik P; Hajek R
Leuk Res; 2010 Aug; 34(8):1007-11. PubMed ID: 20096458
[TBL] [Abstract][Full Text] [Related]
16. Gene signature combinations improve prognostic stratification of multiple myeloma patients.
Chng WJ; Chung TH; Kumar S; Usmani S; Munshi N; Avet-Loiseau H; Goldschmidt H; Durie B; Sonneveld P
Leukemia; 2016 May; 30(5):1071-8. PubMed ID: 26669975
[TBL] [Abstract][Full Text] [Related]
17. The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition.
Chng WJ; Braggio E; Mulligan G; Bryant B; Remstein E; Valdez R; Dogan A; Fonseca R
Blood; 2008 Feb; 111(3):1603-9. PubMed ID: 18006703
[TBL] [Abstract][Full Text] [Related]
18. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
Decaux O; Lodé L; Magrangeas F; Charbonnel C; Gouraud W; Jézéquel P; Attal M; Harousseau JL; Moreau P; Bataille R; Campion L; Avet-Loiseau H; Minvielle S;
J Clin Oncol; 2008 Oct; 26(29):4798-805. PubMed ID: 18591550
[TBL] [Abstract][Full Text] [Related]
20. Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma.
Kassambara A; Hose D; Moreaux J; Walker BA; Protopopov A; Reme T; Pellestor F; Pantesco V; Jauch A; Morgan G; Goldschmidt H; Klein B
Haematologica; 2012 Apr; 97(4):622-30. PubMed ID: 22102711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
